An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities

NCT05532020 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

SH2B1 Deficiency Obesity
Obesity Associated With PCSK1 Mutation (rs6232 Variant)
SIM1 Deficiency Obesity

Interventions

DRUG: DCCR (diazoxide choline) extended-release tablets

Sponsor

Soleno Therapeutics, Inc.